<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Lucinda Billingham | Kristian Brock</title>
    <link>https://www.kristianbrock.com/authors/lucinda-billingham/</link>
      <atom:link href="https://www.kristianbrock.com/authors/lucinda-billingham/index.xml" rel="self" type="application/rss+xml" />
    <description>Lucinda Billingham</description>
    <generator>Source Themes Academic (https://sourcethemes.com/academic/)</generator><language>en-us</language><lastBuildDate>Fri, 22 Nov 2019 00:00:00 +0000</lastBuildDate>
    <image>
      <url>https://www.kristianbrock.com/img/icon-192.png</url>
      <title>Lucinda Billingham</title>
      <link>https://www.kristianbrock.com/authors/lucinda-billingham/</link>
    </image>
    
    <item>
      <title>A Phase II Clinical Trial Design for Associated Co-primary Efficacy and Toxicity Outcomes with Baseline Covariates</title>
      <link>https://www.kristianbrock.com/publication/peps2-design/</link>
      <pubDate>Fri, 22 Nov 2019 00:00:00 +0000</pubDate>
      <guid>https://www.kristianbrock.com/publication/peps2-design/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Implementing the EffTox dose-finding design in the Matchpoint trial</title>
      <link>https://www.kristianbrock.com/publication/matchpoint-design/</link>
      <pubDate>Thu, 20 Jul 2017 00:00:00 +0000</pubDate>
      <guid>https://www.kristianbrock.com/publication/matchpoint-design/</guid>
      <description></description>
    </item>
    
  </channel>
</rss>
